tiprankstipranks
Trending News
More News >
Akari Therapeutics (AKTX)
NASDAQ:AKTX
US Market
Advertisement

Akari Therapeutics (AKTX) Technical Analysis

Compare
305 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Akari Therapeutics’s (AKTX) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Akari Therapeutics is a Sell.
Akari Therapeutics’s (AKTX) 20-Day exponential moving average is 0.94, while Akari Therapeutics’s (AKTX) share price is $1.05, making it a Buy.
Akari Therapeutics’s (AKTX) 50-Day exponential moving average is 0.95, while Akari Therapeutics’s (AKTX) share price is $1.05, making it a Buy.

Akari Therapeutics (AKTX) Pivot Points

Oct 09, 2025, 01:43 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.91
0.96
1.01
1.06
1.10
1.15
1.19
Fibonacci
0.96
1.00
1.02
1.06
1.09
1.11
1.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akari Therapeutics (AKTX) Moving Averages

Oct 09, 2025, 01:43 PM
Period
Simple
Exponential
MA5
0.99Buy
1.01Buy
MA10
1.00Buy
0.98Buy
MA20
0.91Buy
0.94Buy
MA50
0.91Buy
0.95Buy
MA100
1.05Sell
1.03Sell
MA200
1.12Sell
1.18Sell
Akari Therapeutics’s (AKTX) 10-Day exponential moving average is 0.98, while Akari Therapeutics’s (AKTX) share price is $1.05, making it a Buy.
Akari Therapeutics’s (AKTX) 100-Day exponential moving average is 1.03, while Akari Therapeutics’s (AKTX) share price is $1.05, making it a Sell.
Akari Therapeutics’s (AKTX) stock price is $1.05 and Akari Therapeutics’s (AKTX) 50-day simple moving average is 0.91, creating a Buy signal.
Akari Therapeutics’s (AKTX) stock price is $1.05 and Akari Therapeutics’s (AKTX) 100-day simple moving average is 1.05, creating a Sell signal.
Akari Therapeutics’s (AKTX) stock price is $1.05 and Akari Therapeutics’s (AKTX) 200-day simple moving average is 1.12, creating a Sell signal.

Akari Therapeutics (AKTX) Technical Indicators

Oct 09, 2025, 01:43 PM
Name
Value
Implied Action
RSI (14)
56.81
Neutral
STOCH (9,6)
48.76
Neutral
STOCHRSI (14)
59.52
Neutral
MACD (12,26)
0.04
Sell
ADX (14)
21.03
Neutral
Williams %R
-44.09
Buy
CCI (14)
73.22
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
42.04
Neutral
ROC
27.50
Buy
Akari Therapeutics’s (AKTX) Relative Strength Index (RSI) is 56.81, creating a Neutral signal.
Akari Therapeutics’s (AKTX) Trend Strength Indicator (ADX) is 21.03, creating a Neutral signal.
Akari Therapeutics’s (AKTX) Commodity Channel Index (CCI) is 73.22, creating a Neutral signal.
Akari Therapeutics’s (AKTX) Price Rate of Change (ROC) is 27.50, creating a Buy signal.

FAQ

Is AKTX a Buy, Hold, or Sell?
Based on AKTX’s technical indicators, AKTX is a Buy.
    What is AKTX’s RSI (14)?
    AKTX’s RSI (14) is 56.81, which suggests AKTX is a Neutral.
      What is AKTX’s MACD?
      AKTX’s MACD is 0.04, which suggests AKTX is a Sell.
        What is AKTX’s 5-day moving average?
        AKTX’s 5-day moving average is 0.99, which suggests AKTX is a Buy.
          What is AKTX’s 20-day moving average?
          AKTX 20-day moving average is 0.91, which suggests AKTX is a Buy.
            What is AKTX’s 50-day moving average?
            AKTX’s 50-day moving average is 0.91, which suggests AKTX is a Buy.
              What is AKTX’s 200-day moving average?
              AKTX’s 200-day moving average is 1.12, which suggests AKTX is a Sell.
                What is AKTX’s Williams % R (14)?
                AKTX’s Williams % R (14) is -44.09, which suggests AKTX is a Buy.
                  What is AKTX’s CCI (14)?
                  AKTX’s CCI (14) is 73.22, which suggests AKTX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis